Conclusions: Gender-related differences exist in the pharmacokinetics of buprenorphine; differences in body composition appear to have a major impact; differences in CYPA-dependent metabolism may also contribute. (Source: Drug and Alcohol Dependence)
Gender differences in pharmacokinetics of maintenance dosed buprenorphine
Previous post: Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care
Next post: Compensation Effects on Clinical Trial Data Collection in Opioid-Dependent Young Adults.